Clark Eliana Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$578,900.55

Insider Activity of Clark Eliana

According to the SEC Form 4 filings, Clark Eliana, being in a position of

  1. EVP, Chief Technical Officer at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10122 shares for $95,998,
    over all time since 2023-01-03, has bought 0 shares, and sold 32702 shares for $684,934.

Biography of Clark Eliana

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $95,9982100

Comparison of Insiders on Amount of Buys and Sells

2026-03-02SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
607
0.0005%
$13.78$8,364-16.84%
2026-01-05SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
9,515
0.0089%
$9.21$87,633+36.93%
2025-07-01SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
1,022
0.001%
$9.82$10,036+29.35%
2025-03-04SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
679
0.0006%
$8.99$6,104+13.08%
2025-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
7,422
0.0073%
$12.18$90,400-19.95%
2025-01-02SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
556
0.0005%
$12.03$6,689-20.46%
2024-07-01SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
405
0.0004%
$22.93$9,287-45.93%
2024-03-04SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
605
0.0006%
$32.99$19,959-33.73%
2024-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
4,608
0.0052%
$29.50$135,954-22.09%
2023-07-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
360
0.0004%
$40.51$14,584-30.59%
2023-06-20SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
5,000
0.0059%
$45.00$225,000-33.93%
2023-01-04SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
1,692
0.0018%
$37.21$62,959-3.42%
2023-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Technical Officer
231
0.0003%
$34.48$7,965+9.12%
Total: 13
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.